Home Cardiac Dimensions

Cardiac Dimensions

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System

Cardiac Dimensions July 1, 2019

Carillon Mitral Contour System® has been implanted in 1,000 patients in the United States, Europe, Australia, Turkey and the Middle East.

LEARN MORE

CARILLON Pivotal Trial Update: First Patient Randomized

Cardiac Dimensions September 19, 2018

9/19/18: “Current treatments to improve the quality of life for patients with FMR fall short and many heart failure patients are too frail for open-heart surgery,” said Samir Kapadia, M.D., interventional cardiologist and Cath Lab director at the Heart & Vascular Institute, Cleveland Clinic, and one of the principal investigators of the CARILLON Pivotal Trial.

LEARN MORE

Cardiac Dimensions Announces $39 Million Series B Financing for Innovative Device to Treat Patients With Heart Failure

Cardiac Dimensions April 26, 2018

4/26/18: The funds will be used for clinical studies and commercial expansion in the European Union and Australia.

LEARN MORE

RECENT COMMENTS

Helen on New Study Validates Rigorous Safety Measures Needed To Reduce Mercury Exposure During Dental Amalgam Filling Removal

JP on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Teresa Franklin on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Cynthia Easter on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Rob Abbot on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Teresa Franklin on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Eugenia McGrath on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Helen on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Molly Hauck on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Eric Uram on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Patrick on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Michael Bender on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

ganka on New Cochlear™ Nucleus Sound Processor® Profile™ Plus Series Cochlear Implant and Nucleus 7 Sound Processor Receive FDA Approval

Airtech Equipment Pte Ltd on Leaf Healthcare, Inc. Acquired by Smith & Nephew

Harry on Experts Discuss How They’ve Adopted TransCarotid Artery Revascularization (TCAR)

Juan C Parodi on From Resistance to Standard of Care: Gaining Acceptance for Technology to Prevent Stroke

Bergantini Hélio on First Patient Treated in First-in-Man Study of Deep Vein Thrombosis Treatment Designed to Remove Wall-Adherent Clot in Single Session, without Thrombolytic Drugs

Osama on First Patient Treated in First-in-Man Study of Deep Vein Thrombosis Treatment Designed to Remove Wall-Adherent Clot in Single Session, without Thrombolytic Drugs

dr.ashwin bhammar on From Resistance to Standard of Care: Gaining Acceptance for Technology to Prevent Stroke

Ilene on From Resistance to Standard of Care: Gaining Acceptance for Technology to Prevent Stroke

Amy Lewis on From Resistance to Standard of Care: Gaining Acceptance for Technology to Prevent Stroke

M Subramaniam on Negative Abdominal Aortic Aneurysm NICE Guidelines is A Step Backward: Don’t be Fooled by Them

Harry on Negative Abdominal Aortic Aneurysm NICE Guidelines is A Step Backward: Don’t be Fooled by Them

Sherif on Negative Abdominal Aortic Aneurysm NICE Guidelines is A Step Backward: Don’t be Fooled by Them